The KEYNOTE-590, ESCORT-1st, CHECKMATE-648, and ASTRUM-007 trials showed that ICIs combined with chemotherapy did not benefit patients with ESCC with low PD-L1 expression (CPS<10). The gene discussed is CD274; the disease is esophageal squamous cell carcinoma.